Charles F. Wagner, Jr
2019
In 2019, Charles F. Wagner, Jr earned a total compensation of $3.5M as EVP & Chief Financial Officer at Vertex Pharmaceuticals.
Compensation breakdown
| Bonus | $140,000 |
|---|---|
| Non-Equity Incentive Plan | $992,250 |
| Option Awards | $600,039 |
| Salary | $492,692 |
| Stock Awards | $1,225,383 |
| Other | $36,849 |
| Total | $3,487,213 |
Wagner received $1.2M in stock awards, accounting for 35% of the total pay in 2019.
Wagner also received $140K in bonus, $992.3K in non-equity incentive plan, $600K in option awards, $492.7K in salary and $36.8K in other compensation.
Rankings
In 2019, Charles F. Wagner, Jr's compensation ranked 3,495th out of 13,971 executives tracked by ExecPay. In other words, Wagner earned more than 75.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,495 out of 13,971 | 75th |
Division Manufacturing | 1,264 out of 5,692 | 78th |
Major group Chemicals And Allied Products | 433 out of 2,189 | 80th |
Industry group Drugs | 360 out of 1,875 | 81st |
Industry Pharmaceutical Preparations | 271 out of 1,387 | 81st |
Source: SEC filing on April 28, 2020.
Wagner's colleagues
We found six more compensation records of executives who worked with Charles F. Wagner, Jr at Vertex Pharmaceuticals in 2019.
2019
Jeffrey Leiden
Vertex Pharmaceuticals
Chairman
2019
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2019
Reshma Kewalramani
Vertex Pharmaceuticals
Chief Executive Officer
2019
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Patient Officer
2019
Paul Silva
Vertex Pharmaceuticals
SVP & Corporate Controller
2019
Ian Smith
Vertex Pharmaceuticals